JUNCTURE WEALTH STRATEGIES, LLC

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1632866 SCOTTSDALE, AZ

Back to KNSA Full portfolio

Position in KNSA

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$1,139,844

+$683,864 QoQ

Shares Held

17,824

+88.2% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

1.64%

of 13F equity value

Holder Rank

#123

of 266 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JUNCTURE WEALTH STRATEGIES, LLC holds $3,368,884 across 4 Drug Manufacturers - Specialty & Generic names. KNSA ranks #1 (33.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KNSA	Kiniksa Pharmaceuticals International, plc This page	17,824	$1,139,844
2	ETON	Eton Pharmaceuticals, Inc.	28,849	$1,044,333
3	NBIX	Neurocrine Biosciences Inc	5,262	$886,857
4	SUPN	Supernus Pharmaceuticals, Inc.	6,404	$297,850

All Filings in KNSA

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,139,844	17,824	+88.2%	Shares	Sole	2026-07-09
2026-03-31	$455,980	9,470	+16.3%	Shares	Sole	2026-04-15
2025-12-31	$336,022	8,146	+18.7%	Shares	Sole	2026-01-27
2025-09-30	$266,529	6,864	—	Shares	Sole	2025-10-14
No filing history on record for this holder in this stock.